Complete hydatidiform mole

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:254688OMIM:231090O01.0
Who is this for?
Show terms as
3Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

A complete hydatidiform mole (CHM), also known as a complete molar pregnancy, is an abnormal form of pregnancy in which no embryo develops and the placental tissue grows into a mass of cyst-like structures resembling a cluster of grapes. It is classified as a type of gestational trophoblastic disease (GTD). In a complete mole, all genetic material comes from the father (androgenetic origin), most commonly arising when a single sperm fertilizes an empty egg and then duplicates its chromosomes (46,XX), or less frequently when two sperm fertilize an empty egg (46,XX or 46,XY). The condition affects the reproductive system and, if not properly managed, can lead to serious complications including persistent gestational trophoblastic neoplasia (GTN), a malignant condition. Key symptoms include abnormal vaginal bleeding during the first trimester, a uterus that is larger than expected for gestational age, markedly elevated levels of human chorionic gonadotropin (hCG), absence of fetal heart tones, and passage of grape-like vesicles. Patients may also experience severe nausea and vomiting (hyperemesis gravidarum), preeclampsia occurring unusually early in pregnancy, ovarian theca lutein cysts, and rarely hyperthyroidism. Ultrasound typically reveals a characteristic "snowstorm" pattern with no identifiable fetus. Treatment involves uterine evacuation by suction curettage, which is the standard first-line approach. Following evacuation, serial monitoring of serum hCG levels is essential to ensure complete resolution and to detect any progression to gestational trophoblastic neoplasia, which occurs in approximately 15–20% of complete molar pregnancies. If hCG levels plateau or rise after evacuation, chemotherapy is indicated. Most patients with GTN following a complete mole respond well to single-agent chemotherapy (methotrexate or actinomycin D) and have excellent cure rates. Reliable contraception is recommended during the hCG monitoring period, which typically lasts 6–12 months. Rare familial forms of recurrent hydatidiform mole exist, associated with biparental (rather than androgenetic) origin, caused by mutations in genes such as NLRP7 or KHDC3L, inherited in an autosomal recessive pattern.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Complete hydatidiform mole.

View clinical trials →

No actively recruiting trials found for Complete hydatidiform mole at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Complete hydatidiform mole community →

Specialists

3 foundView all specialists →
IM
Ignatia B Van den Veyver, MD
Specialist
PI on 3 active trials1 Complete hydatidiform mole publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Complete hydatidiform mole.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Complete hydatidiform moleForum →

No community posts yet. Be the first to share your experience with Complete hydatidiform mole.

Start the conversation →

Latest news about Complete hydatidiform mole

No recent news articles for Complete hydatidiform mole.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Complete hydatidiform mole

What is Complete hydatidiform mole?

A complete hydatidiform mole (CHM), also known as a complete molar pregnancy, is an abnormal form of pregnancy in which no embryo develops and the placental tissue grows into a mass of cyst-like structures resembling a cluster of grapes. It is classified as a type of gestational trophoblastic disease (GTD). In a complete mole, all genetic material comes from the father (androgenetic origin), most commonly arising when a single sperm fertilizes an empty egg and then duplicates its chromosomes (46,XX), or less frequently when two sperm fertilize an empty egg (46,XX or 46,XY). The condition affec

At what age does Complete hydatidiform mole typically begin?

Typical onset of Complete hydatidiform mole is adult. Age of onset can vary across affected individuals.

Which specialists treat Complete hydatidiform mole?

3 specialists and care centers treating Complete hydatidiform mole are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.